Related Experiment Video
Updated: Jun 12, 2026
Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
Published on: August 23, 2024
Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL
Claudia Philipp1, Jennifer Edelmann, Andreas Bühler
1Institute of Cell Biology, University of Duisburg-Essen, Medical School, Essen, Germany.
Abstract:
Chronic lymphocytic leukemia (CLL) cells show constitutive nuclear factor kappa B (NF-κB) activation, which may have a pathogenetic role. The mechanisms causing this NF-κB activity are poorly understood. A20, encoded by the TNFAIP3 gene, is a repressor of the NF-κB pathway and was recently shown to be frequently inactivated by deletions and/or point mutations in several types of B-cell lymphomas. Here, we studied 48 CLL, including at least 12 cases with a deletion of one allele of TNFAIP3, for mutations. However, only one case harboured a silent mutation, all other cases were unmutated. Therefore, A20 inactivation plays no significant role in the pathogenesis of CLL, and the recurrent deletion in CLL on 6q21-23, where TNFAIP3 is located, likely affects other gene(s).
Insights
A20 gene inactivation is not a significant factor in chronic lymphocytic leukemia (CLL) pathogenesis. Researchers found no significant mutations in TNFAIP3, the gene encoding A20, in CLL patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Constitutive nuclear factor kappa B (NF-κB) activation is observed in chronic lymphocytic leukemia (CLL) cells, suggesting a potential pathogenetic role.
- The underlying mechanisms driving NF-κB activation in CLL remain largely unknown.
- A20, a repressor of the NF-κB pathway encoded by the TNFAIP3 gene, is frequently inactivated in other B-cell lymphomas.
Purpose of the Study:
- To investigate the role of A20 inactivation, via mutations or deletions in the TNFAIP3 gene, in the pathogenesis of chronic lymphocytic leukemia (CLL).
Main Methods:
- Analysis of TNFAIP3 gene mutations and deletions in a cohort of 48 chronic lymphocytic leukemia (CLL) patients.
- Specific focus on cases with known deletions within the 6q21-23 region, where TNFAIP3 is located.
Main Results:
- Only one case of CLL exhibited a silent mutation in the TNFAIP3 gene; all other cases were unmutated.
- No significant role for A20 inactivation was identified in the pathogenesis of CLL.
- The recurrent deletion on chromosome 6q21-23 in CLL may impact other genes besides TNFAIP3.
Conclusions:
- A20 inactivation is not a significant driver in the pathogenesis of chronic lymphocytic leukemia (CLL).
- The observed deletions in the 6q21-23 region in CLL likely affect genes other than TNFAIP3.
- Further research is needed to identify the specific genes affected by 6q21-23 deletions in CLL.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...